NASDAQ:ALECAlector Stock Price, Forecast & News

Alector's stock was trading at $24.92 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ALEC stock has decreased by 4.5% and is now trading at $23.81. View which stocks have been most impacted by Coronavirus.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alector in the last year. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Alector.

Alector is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020. View our earnings forecast for Alector.

Alector Inc (NASDAQ:ALEC) posted its quarterly earnings data on Wednesday, May, 13th. The company reported ($0.53) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.43) by $0.10. The business had revenue of $7.17 million for the quarter, compared to the consensus estimate of $10.60 million. Alector had a negative net margin of 556.70% and a negative return on equity of 48.29%. View Alector's earnings history.

8 brokerages have issued 12-month price targets for Alector's shares. Their forecasts range from $28.00 to $41.00. On average, they expect Alector's share price to reach $33.00 in the next twelve months. This suggests a possible upside of 38.6% from the stock's current price. View analysts' price targets for Alector.

Press coverage about ALEC stock has been trending negative recently, according to InfoTrie. The research group ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Alector earned a coverage optimism score of -2.2 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 5.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the company's share price in the immediate future. View the latest news about Alector.

Alector saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 5,760,000 shares, an increase of 11.6% from the June 15th total of 5,160,000 shares. Based on an average daily trading volume, of 492,100 shares, the short-interest ratio is currently 11.7 days. Approximately 11.1% of the company's stock are short sold. View Alector's Current Options Chain.

Some companies that are related to Alector include Repligen (RGEN), Adaptive Biotechnologies (ADPT), Allogene Therapeutics (ALLO), Acceleron Pharma (XLRN), Crispr Therapeutics (CRSP), Novavax (NVAX), Spark Therapeutics (ONCE), China Biologic Products (CBPO), Halozyme Therapeutics (HALO), Ablynx (ABLYF), Momenta Pharmaceuticals (MNTA), Iovance Biotherapeutics (IOVA), bluebird bio (BLUE), Fate Therapeutics (FATE) and Denali Therapeutics (DNLI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Alector investors own include Editas Medicine (EDIT), NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Gossamer Bio (GOSS), Cisco Systems (CSCO), Harpoon Therapeutics (HARP), Johnson & Johnson (JNJ), Kaleido Biosciences (KLDO) and AT&T (T).

(ALEC) raised $177 million in an initial public offering on Thursday, February 7th 2019. The company issued 9,300,000 shares at $18.00-$20.00 per share. Morgan Stanley, BofA Merrill Lynch, Cowen and Barclays served as the underwriters for the IPO.

Alector trades on the NASDAQ under the ticker symbol "ALEC."

Shares of ALEC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ALEC stock can currently be purchased for approximately $23.81.

Alector has a market capitalization of $1.88 billion and generates $21.22 million in revenue each year. The company earns $-105,390,000.00 in net income (profit) each year or ($1.71) on an earnings per share basis. Alector employs 91 workers across the globe.

The official website for Alector is www.alector.com.

Alector's mailing address is 131 OYSTER POINT BLVD. SUITE 600, SOUTH SAN FRANCISCO CA, 94080. The company can be reached via phone at 415-231-5660 or via email at [email protected]